Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 30 Issue 3, March 2012

Teasel and Fields (Small), oil on aluminum, 2009. This issue brings together several articles on technologies for breeding plants for food, fuel or the production of industrial chemicals and biopharmaceuticals. Artwork by John Knight.

Volume 30 Issue 3

Subscribe

Editorial

  • Averting a global food crisis will require the deconstruction of several hurdles to the deployment of new strategies in plant breeding.

    Editorial

    Advertisement

  • The US Food and Drug Administration (FDA) has raised the bar very high for those who seek to make a business out of biosimilars.

    Editorial
Top of page ⤴

News

Top of page ⤴

Data Page

Top of page ⤴

Opinion

  • Galvanizing plant science in Europe will depend on an overhaul of the tangle of indefensible regulations themselves, not on the advent of new plant breeding technologies that may escape existing rules.

    • L Val Giddings
    • Ingo Potrykus
    • Nina V Fedoroff
    Opinion
Top of page ⤴

News Feature

  • As parts of the developing world embrace biotech, the focus is shifting from food production to fuels, industrial chemicals and even drugs. Daniel Grushkin investigates.

    • Daniel Gruskin
    News Feature

  • New techniques for manipulating plant genomes are yielding plants touted as nontransgenic. Will that relieve regulatory burden? Emily Waltz investigates.

    • Emily Waltz
    News Feature
Top of page ⤴

Bioentrepreneur

Top of page ⤴

Correspondence

Top of page ⤴

Feature

  • The first crops obtained through new plant breeding techniques are close to commercialization. Regulatory issues will determine the adoption of the techniques by breeders.

    • Maria Lusser
    • Claudia Parisi
    • Emilio Rodríguez-Cerezo
    Feature
Top of page ⤴

Patents

Top of page ⤴

News & Views

  • An improved method for analyzing deep RNA sequencing data provides a comprehensive view of RNA editing sites.

    • Lior Pachter
    News & Views

  • When human blastocysts are cultured in vitro to derive embryonic stem cells, they undergo profound molecular changes that alter their identity.

    • Ariel Pribluda
    • Jacob H Hanna
    News & Views

  • A comprehensive study of ligand binding to the human PARP family of proteins reveals the molecular basis of inhibitor selectivity and promiscuity.

    • Philip Jones
    News & Views
Top of page ⤴

Research Highlights

Top of page ⤴

Analysis

Top of page ⤴

Brief Communication

Top of page ⤴

Article

Top of page ⤴

Letter

Top of page ⤴

Resource

Top of page ⤴

Careers and Recruitment

Top of page ⤴

In This Issue

Top of page ⤴

Focus

  • Sixteen years after the commercialization of crops produced by traditional transgenic technology, a raft of new approaches are opening new opportunities in plant biotechnology. This focus issue of Nature Biotechnologyhighlights these technologies and their impact on plant breeding and their impact on regulatory oversight.

    Focus
Top of page ⤴

Search

Advanced search

Quick links